Adjuvant Endocrine Therapy for Breast Cancer During Perimenopause

被引：1
|
作者：
Noss, D. [1 ]
Buchholz, S. [1 ]
Ortmann, O. [1 ]
机构：
[1] Univ Regensburg, Klin Frauenheilkunde & Geburtshilfe, D-93053 Regensburg, Germany
来源：
GEBURTSHILFE UND FRAUENHEILKUNDE | 2010年 / 70卷 / 02期
关键词：
perimenopause; breast cancer; endocrine therapy; menopausal status; PREMENOPAUSAL WOMEN; AROMATASE INHIBITORS; HORMONE; CHEMOTHERAPY; METAANALYSIS; TAMOXIFEN;
D O I：
10.1055/s-0029-1240825
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
Adjuvant endocrine treatment plays an important role in the treatment of estrogen responsive breast cancer. The treatment options for premenopausal women differ from those for postmenopausal women. Aromatase inhibitors (AI) improve the outcomes in postmenopausal women, while AI can induce an increase in estrogen secretion and tumor growth in premenopausal women. The standard therapy during premenopause remains tamoxifen with or without ovarian suppression by GnRH analogues. Treatment of perimenopausal breast cancer patients can be more complicated, because it is often difficult to determine menopausal status.
引用
收藏
页码：112 / 116
页数：5
相关论文
共 50 条
  • [31] Racial disparities in initiation of adjuvant endocrine therapy of early breast cancer
    Reeder-Hayes, Katherine E.
    Meyer, Anne Marie
    Dusetzina, Stacie B.
    Liu, Huan
    Wheeler, Stephanie B.
    BREAST CANCER RESEARCH AND TREATMENT, 2014, 145 (03) : 743 - 751
  • [32] Sexual dysfunction in women on adjuvant endocrine therapy after breast cancer
    Baumgart, Juliane
    Nilsson, Kerstin
    Evers, Anneli Stavreus
    Kallak, Theodora Kunovac
    Poromaa, Inger Sundstrom
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2013, 20 (02): : 162 - 168
  • [33] Adjuvant Endocrine Therapy for Early Breast Cancer: The Story So Far
    Gradishar, William J.
    CANCER INVESTIGATION, 2010, 28 (04) : 433 - 442
  • [34] Adjuvant Endocrine Therapy and Bone Health in Breast Cancer
    Clines, Gregory A.
    Choksi, Palak
    Van Poznak, Catherine
    CURRENT OSTEOPOROSIS REPORTS, 2015, 13 (05) : 263 - 273
  • [35] Compliance and persistence of endocrine adjuvant breast cancer therapy
    Uwe Güth
    Mary Elizabeth Myrick
    Nerbil Kilic
    Serenella Eppenberger-Castori
    Seraina Margaretha Schmid
    Breast Cancer Research and Treatment, 2012, 131 : 491 - 499
  • [36] ADJUVANT ENDOCRINE THERAPY FOR OPERABLE BREAST-CANCER
    STEWART, HJ
    BULLETIN DU CANCER, 1991, 78 (04) : 379 - 384
  • [37] Adjuvant Endocrine Therapy in Premenopausal Women With Breast Cancer
    Kadakia, Kunal C.
    Henry, N. Lynn
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (10) : 663 - 672
  • [38] Compliance and persistence of endocrine adjuvant breast cancer therapy
    Gueth, Uwe
    Myrick, Mary Elizabeth
    Kilic, Nerbil
    Eppenberger-Castori, Serenella
    Schmid, Seraina Margaretha
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 131 (02) : 491 - 499
  • [39] Adjuvant endocrine therapy in postmenopausal breast cancer patients
    Köberle, D
    Thürlimann, B
    BREAST, 2005, 14 (06) : 446 - 451
  • [40] The effects of adjuvant endocrine therapy on bone health in women with breast cancer
    Ramchand, Sabashini K.
    Cheung, Yee-Ming
    Yeo, Belinda
    Grossmann, Mathis
    JOURNAL OF ENDOCRINOLOGY, 2019, 241 (03) : R111 - R124
12345